
Andrew Young
Ask VT AI
View News Summary
- Novartis is in advanced talks to acquire U.S. biotech Avidity Biosciences for over $12 billion, bolstering its neuroscience and RNA strategy.
- LSU officials in high-level discussions about Brian Kelly's future after a blowout loss to Texas A&M, with a potential buyout complicating matters.
- Arsenal extend lead, Villa stun City in tight Premier League clash
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis is in advanced talks to acquire U.S. biotech Avidity Biosciences for over $12 billion, bolstering its neuroscience and RNA strategy.
- LSU officials in high-level discussions about Brian Kelly's future after a blowout loss to Texas A&M, with a potential buyout complicating matters.
- Arsenal extend lead, Villa stun City in tight Premier League clash
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Andrew Young
News from Andrew Young
